Abiopharma

FORM N-2- POST-EFFECTIVE AMENDMENT NO. 6

Crinetics Pharmaceuticals Solicita Autorização de Comercialização de Palsonify™ (Paltusotina) no Brasil para Tratamento de Acromegalia

Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that toz

Notice of the Annual General Meeting to Approve the 2025 Financial Statements, Scheduled for May 22, 2026, and Changes to the Atos Board of Directors

Convocation de l’assemblée générale annuelle d’approbation des comptes 2025 prévue le 22 mai 2026 et évolution du conseil d’administration d’Atos

SalMar – Integrert årsrapport 2025

PDMR Shareholdings

SalMar – Integrated annual report 2025

The company’s liability balance as of 31.12.25, by repayment dates

Omdia：顶级云厂商加码AI基础设施，2025年第四季度，全球云基础设施支出增长29%